DK528889A - Substituerede quinolinderivater og fremgangsmaade til fremstilling deraf, mellemprodukter til anvendelse ved deres fremstilling og farmaceutiske midler indeholdende derivaterne - Google Patents
Substituerede quinolinderivater og fremgangsmaade til fremstilling deraf, mellemprodukter til anvendelse ved deres fremstilling og farmaceutiske midler indeholdende derivaterneInfo
- Publication number
- DK528889A DK528889A DK528889A DK528889A DK528889A DK 528889 A DK528889 A DK 528889A DK 528889 A DK528889 A DK 528889A DK 528889 A DK528889 A DK 528889A DK 528889 A DK528889 A DK 528889A
- Authority
- DK
- Denmark
- Prior art keywords
- alkoxy
- alkyl
- derivatives
- intermediates
- preparing
- Prior art date
Links
- 239000000543 intermediate Substances 0.000 title abstract 2
- 238000000034 method Methods 0.000 title abstract 2
- 239000008177 pharmaceutical agent Substances 0.000 title abstract 2
- SMWDFEZZVXVKRB-UHFFFAOYSA-N Quinoline Chemical class N1=CC=CC2=CC=CC=C21 SMWDFEZZVXVKRB-UHFFFAOYSA-N 0.000 title 1
- 229940027991 antiseptic and disinfectant quinoline derivative Drugs 0.000 title 1
- 125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 8
- 125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 3
- 150000002431 hydrogen Chemical group 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 abstract 2
- 125000006700 (C1-C6) alkylthio group Chemical group 0.000 abstract 1
- 125000005913 (C3-C6) cycloalkyl group Chemical group 0.000 abstract 1
- 125000003917 carbamoyl group Chemical group [H]N([H])C(*)=O 0.000 abstract 1
- 125000003178 carboxy group Chemical group [H]OC(*)=O 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- -1 cyano, hydroxyl Chemical group 0.000 abstract 1
- 230000027119 gastric acid secretion Effects 0.000 abstract 1
- 229910052736 halogen Inorganic materials 0.000 abstract 1
- 150000002367 halogens Chemical group 0.000 abstract 1
- 125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 1
- 239000003112 inhibitor Substances 0.000 abstract 1
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 1
- 230000001225 therapeutic effect Effects 0.000 abstract 1
- 125000002023 trifluoromethyl group Chemical group FC(F)(F)* 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
- C07D215/44—Nitrogen atoms attached in position 4 with aryl radicals attached to said nitrogen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/38—Nitrogen atoms
- C07D215/42—Nitrogen atoms attached in position 4
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (4)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB888804444A GB8804444D0 (en) | 1988-02-25 | 1988-02-25 | Compounds |
| GB8804444 | 1988-02-25 | ||
| EP8900175 | 1989-02-20 | ||
| PCT/EP1989/000175 WO1989008104A1 (en) | 1988-02-25 | 1989-02-20 | 4-amino-3-acylquinoline derivatives and their use as inhibitors of gastric secretion |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| DK528889D0 DK528889D0 (da) | 1989-10-24 |
| DK528889A true DK528889A (da) | 1989-10-24 |
| DK166623B1 DK166623B1 (da) | 1993-06-21 |
Family
ID=10632376
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK528889A DK166623B1 (da) | 1988-02-25 | 1989-10-24 | Terapeutisk aktive 4-phenylamino-quinolinderivater, fremgangsmaader til fremstilling deraf samt farmaceutiske midler indeholdende derivaterne |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US5089504A (da) |
| EP (1) | EP0330485B1 (da) |
| JP (1) | JPH0774204B2 (da) |
| KR (1) | KR0159083B1 (da) |
| CN (2) | CN1027368C (da) |
| AU (1) | AU606508B2 (da) |
| CA (1) | CA1332839C (da) |
| CZ (1) | CZ398391A3 (da) |
| DE (1) | DE68906687T2 (da) |
| DK (1) | DK166623B1 (da) |
| ES (1) | ES2055037T3 (da) |
| FI (1) | FI93952C (da) |
| GB (1) | GB8804444D0 (da) |
| HU (1) | HU208814B (da) |
| IE (1) | IE63239B1 (da) |
| IL (1) | IL89346A (da) |
| MY (1) | MY105158A (da) |
| NZ (1) | NZ228098A (da) |
| PT (1) | PT89789B (da) |
| WO (1) | WO1989008104A1 (da) |
| ZA (1) | ZA891402B (da) |
| ZW (1) | ZW1989A1 (da) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8918265D0 (en) * | 1989-08-10 | 1989-09-20 | Smithkline Beckman Intercredit | Compounds |
| US5215999A (en) * | 1990-03-28 | 1993-06-01 | Otsuka Pharmaceutical Co., Ltd. | Quinoline derivative and antiulcer agent containing said quinoline derivative |
| FI933376L (fi) * | 1991-01-29 | 1993-07-28 | Smithkline Beecham Intercredit | 4-amino-3-acylkinolinderivater och deras anvaendning som inhibitorer avmagsyrasekretion |
| GB9126438D0 (en) * | 1991-12-12 | 1992-02-12 | Smithkline Beecham Intercredit | New quinoline derivatives |
| US5362743A (en) * | 1993-03-09 | 1994-11-08 | Pfizer Inc. | Aminoquinoline derivatives |
| IS4164A (is) * | 1993-06-11 | 1994-12-12 | Ab Astra | Efnasambönd sem hindra flæði magasýru |
| US5556863A (en) * | 1993-06-11 | 1996-09-17 | Astra Aktiebolag | Compound for gastric acid secretion inhibition |
| SE9302005D0 (sv) | 1993-06-11 | 1993-06-11 | Ab Astra | New active compounds |
| EP1086094A1 (en) | 1998-05-23 | 2001-03-28 | Byk Gulden Lomberg Chemische Fabrik GmbH | Quinoline-aminomethyl-pyridyl derivatives with anti-helicobacter activity |
| US6852739B1 (en) | 1999-02-26 | 2005-02-08 | Nitromed Inc. | Methods using proton pump inhibitors and nitric oxide donors |
| HN2000000203A (es) | 1999-11-30 | 2001-06-13 | Pfizer Prod Inc | Procedimiento para la obtencion de 1,2,3,4-tetrahidroquinolinas 4-carboxiamino-2- sustituidas. |
| UA80393C2 (uk) | 2000-12-07 | 2007-09-25 | Алтана Фарма Аг | Фармацевтична композиція, яка містить інгібітор фде 4, диспергований в матриці |
| US20050020637A1 (en) * | 2001-11-19 | 2005-01-27 | Wolfgang-Alexander Simon | Agents for the treatment of airway disorders |
| MY140561A (en) | 2002-02-20 | 2009-12-31 | Nycomed Gmbh | Dosage form containing pde 4 inhibitor as active ingredient |
| AU2003254282A1 (en) | 2002-08-01 | 2004-02-23 | Nitromed, Inc. | Nitrosated proton pump inhibitors, compositions and methods of use |
| DK1606261T3 (da) | 2003-03-10 | 2010-01-18 | Nycomed Gmbh | Hidtil ukendt fremgangsmåde til fremstilling af roflumilast |
| WO2005041961A1 (en) | 2003-11-03 | 2005-05-12 | Astrazeneca Ab | Imidazo [1,2-a] pyridine derivatives for the treatment of silent gastro-esophageal reflux |
| AU2006224619B2 (en) * | 2005-03-16 | 2012-06-07 | Takeda Gmbh | Taste masked dosage form containing roflumilast |
| CN106496119A (zh) * | 2016-10-17 | 2017-03-15 | 江南大学 | 一种n‑苯基‑8‑氨基喹啉的制备方法 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2652398A (en) * | 1949-11-17 | 1953-09-15 | Endo Products Inc | N-substituted-2-amino (methyl) quinolines |
| US3470186A (en) * | 1967-06-02 | 1969-09-30 | American Cyanamid Co | Substituted 4-anilino-3-quinolinecarboxylic acids and esters |
| CA942748A (en) * | 1970-09-18 | 1974-02-26 | Venkatachala L. Narayanan | 1-aziridinylcarbonyl substituted-3-quinolinecarboxylic acid compounds |
| US4343804A (en) * | 1979-03-26 | 1982-08-10 | A. H. Robins Company, Inc. | 4-Amino-3-quinolinecarboxylic acids and esters-antisecretory anti-ulcer compounds |
| ZA801526B (en) * | 1979-03-26 | 1981-08-26 | Robins Co Inc A H | 4-amino-3-quinolinecarboxylic acids and esters-antisecretory, anti-ulcer compounds |
| GB8621425D0 (en) * | 1986-09-05 | 1986-10-15 | Smith Kline French Lab | Compounds |
| GB8804445D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| GB8804446D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
| GB8804443D0 (en) * | 1988-02-25 | 1988-03-23 | Smithkline Beckman Intercredit | Compounds |
-
1988
- 1988-02-25 GB GB888804444A patent/GB8804444D0/en active Pending
-
1989
- 1989-02-20 HU HU891463A patent/HU208814B/hu not_active IP Right Cessation
- 1989-02-20 IL IL8934689A patent/IL89346A/en not_active IP Right Cessation
- 1989-02-20 JP JP1502451A patent/JPH0774204B2/ja not_active Expired - Lifetime
- 1989-02-20 KR KR1019890701954A patent/KR0159083B1/ko not_active Expired - Fee Related
- 1989-02-20 WO PCT/EP1989/000175 patent/WO1989008104A1/en not_active Ceased
- 1989-02-20 AU AU31819/89A patent/AU606508B2/en not_active Ceased
- 1989-02-20 ZW ZW19/89A patent/ZW1989A1/xx unknown
- 1989-02-21 MY MYPI89000210A patent/MY105158A/en unknown
- 1989-02-21 CA CA000591638A patent/CA1332839C/en not_active Expired - Fee Related
- 1989-02-22 NZ NZ228098A patent/NZ228098A/xx unknown
- 1989-02-22 PT PT89789A patent/PT89789B/pt not_active IP Right Cessation
- 1989-02-23 ZA ZA891402A patent/ZA891402B/xx unknown
- 1989-02-23 IE IE56889A patent/IE63239B1/en not_active IP Right Cessation
- 1989-02-23 EP EP89301804A patent/EP0330485B1/en not_active Expired - Lifetime
- 1989-02-23 ES ES89301804T patent/ES2055037T3/es not_active Expired - Lifetime
- 1989-02-23 DE DE89301804T patent/DE68906687T2/de not_active Expired - Fee Related
- 1989-02-23 US US07/314,726 patent/US5089504A/en not_active Expired - Lifetime
- 1989-02-24 CN CN89100929A patent/CN1027368C/zh not_active Expired - Fee Related
- 1989-10-24 FI FI895048A patent/FI93952C/fi not_active IP Right Cessation
- 1989-10-24 DK DK528889A patent/DK166623B1/da not_active IP Right Cessation
-
1991
- 1991-12-20 CZ CS913983A patent/CZ398391A3/cs unknown
-
1994
- 1994-02-26 CN CN94102353A patent/CN1100414A/zh active Pending
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK245888A (da) | 4-aminoquinolinderivater | |
| NO903851D0 (no) | Fremgangsmaate for fremstilling av n-substituerte-4-pyrimidinaminer og -pyrimidindiaminer, og deres anvendelse som medikamenter. | |
| NO170487C (no) | Analogifremgangsmaate til fremstilling av terapeutisk aktive vannloeselige camptothecin-analoger | |
| NO882608L (no) | Fremgangsmaate for fremstilling av terapeutisk aktive pyrazolopyridiner. | |
| ATE175962T1 (de) | Anilin derivate | |
| ATE212026T1 (de) | Halo-substituierte protein kinase c inhibitoren | |
| ES8802610A1 (es) | Un metodo para preparar un compuesto quimico, inhibidor de las 5-lipoxigenasas,util para la terapia humana y veterinaria | |
| DK495781A (da) | Fremgangsmaade til fremstilling af n-substituerede omega-(2-oxoimidazolin-1-yl) alkansyrer og salte og estere deraf | |
| MY105158A (en) | Substituted 4-aminoquinoline derivatives as gastric acid secretion inhibutors. | |
| DK157813C (da) | Analogifremgangsmaade til fremstilling af n-(4-aminobenzoyl)-n'-benzyl bispidinderivater | |
| ATE94535T1 (de) | 4-amino-3-acylchinolin-derivate und ihre verwendung als inhibitoren der magensekretion. | |
| ES2010284A6 (es) | Procedimiento para preparar derivados de tiourea. | |
| DK151965C (da) | Analogifremgangsmaade til fremstilling af piperazinsubstituerede 3-alkyltheobrominforbindelser | |
| DK335486A (da) | Arylethanolhydroxylaminer, fremgangsmaader til deres fremstilling ogderes anvendelse til ydelsesforbedring | |
| ATE100439T1 (de) | 2-(2-hydroxy-3-phenoxypropylamino)-ethoxybenzol derivate. | |
| FI894068A0 (fi) | Sulfonamider med tetrazolylrest, foerfarande foer deras tillverkning och laekemedel. | |
| DK0401093T3 (da) | Hidtil ukendte pyrrolidonderivater, fremgangsmåde til fremstilling heraf og farmaceutiske midler indeholdende disse | |
| SE8405429L (sv) | Forfarande for framstellning av 7-acylindolin-2-oner | |
| NO840732L (no) | Analogifremgangsmaate for fremstilling av den terapeutisk aktive forbindelse n-(3-trifluormetylfenyl)-n`-propargylpiperazin | |
| NO157214C (no) | Analogifremgangsmaate for fremstilling av terapeutisk aktive imidazolcarboxylsyrederivater. | |
| DE3068456D1 (en) | 2-(n-(2-fluoro-6-bromophenyl)-n-(thiemyl-2-methyl)-amino)-2-imidazoline, its addition salts, pharmaceutical compositions containing them and processes for their preparation | |
| DK31987A (da) | 1-acylaminomethyl-imidazo(1,2-a)-quinolin-derivater, fremgangsmaade til fremstilling deraf og laegemidler indeholdende saadanne derivater | |
| DK0586344T3 (da) | Oxazolidinforbindelser og deres anvendelse som lægemidler | |
| DK549085A (da) | 3-aminopropoxyphenylderivater, fremgangsmaade til fremstilling deraf og farmaceutiske praeparater, som indeholder disse derivater | |
| AR002015A1 (es) | DERIVADOS DE ACIDO 8-OXO-5,8-DIHIDRO-6H-DIBENZO (a, g) QUINOLIZINA-13- PROPANOICO, PROCEDIMIENTO PARA SU PREPARACION Y MEDICAMENTO Y COMPOSICIONFARMACEUTICA QUE CONTIENEN A DICHOS DERIVADOS. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| B1 | Patent granted (law 1993) | ||
| PBP | Patent lapsed |